Join
Live feed
·
PRReleasevia Quantisnow
Infinity Pharmaceuticals Inc. logo

Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)

ByQuantisnow·Wall Street's wire, on your screen.
INFI· Infinity Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INFI (Infinity Pharmaceuticals Inc.) and more on Quantisnow.